1. Inicio
  2. Proyectos y Estudios
  3. ESTUDIO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, DE 52 SEMANAS DE DURACIÓN PARA DEMOSTRAR LA EFICACIA, SEGURIDAD Y TOLERABILIDAD DE INYECCIONES SUBCUTÁNEAS DE SECUKINUMAB CON JERINGAS PRECARGADAS DE 2 ML (300 MG) EN PACIENTES A D ULTOS CON PSORIASIS EN PLACAS DE MODERADA A GRAVE - ALLURE.

ESTUDIO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, DE 52 SEMANAS DE DURACIÓN PARA DEMOSTRAR LA EFICACIA, SEGURIDAD Y TOLERABILIDAD DE INYECCIONES SUBCUTÁNEAS DE SECUKINUMAB CON JERINGAS PRECARGADAS DE 2 ML (300 MG) EN PACIENTES A D ULTOS CON PSORIASIS EN PLACAS DE MODERADA A GRAVE - ALLURE.

Datos básicos

Código:
CAIN457A2323
Protocolo:
CAIN457A2323
EUDRACT:
2015-005170-38
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2016
Año de finalización:
ENSAYO CLÍNICO INTERNACIONAL

Objetivos del proyecto

Observaciones: Estado Comité: ACTIVO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

NOVARTIS FARMACEUTICA, S.A.

Resultados del Ensayo Clínico

"Mojito's" phytophotodermatitis, the other "lime" disease

Torres-Navarro, I, Condiño-Brito E, Botella-Estrada, R

Editorial Material. 10.1016/j.medcli.2017.08.008. 2018


"Phytophotodermatitis as a clinical problem and as a therapeutic option: case report and review of the literature".

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1016/j.pdpdt.2023.103304. 2023


[[Tranaslated article]]Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.

López DF; (...); Ortiz-Romero, P. L.

Article. 10.1016/j.ad.2022.11.013. 2023


[[Translated article]]Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).

Couselo-Rodríguez C; (...); Flórez Á

Article. 10.1016/j.ad.2023.07.028. 2024


[[Translated article]]Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.

Sanchez-Diaz, M; (...); Carrascosa-Carrillo, J M

Article. 10.1016/j.ad.2024.01.019. 2024


[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings.

Munera-Campos M; (...); Carrascosa JM

Article. 10.1016/j.ad.2023.05.010. 2023


[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence

Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda

Editorial Material. 10.1016/j.farma.2024.08.009. 2024

  • Open Access.

[Translated article] Fatal outcome in classic Kaposi's sarcoma.

Mansilla-Polo M, Botella-Estrada R

Article. 10.1016/j.ad.2024.03.015. 2024

  • Open Access.

[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Andrés JLP, Solsona MDE

Article. 10.1016/j.farma.2023.10.004. 2024


[Translated article] Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience.

Nieto Benito, L M; (...); Garcia-Doval, I

Article. 10.1016/j.ad.2021.05.027. 2022


[Translated article] New challenges in advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2024.05.001. 2024


[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025


[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.

Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.09.006. 2024

  • Open Access.

[Translated article] Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer - Basal Cell Carcinoma or Squamous Cell Carcinoma - Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.

Minano Medrano, R.; (...); Garcia-Doval, I

Article. 10.1016/j.ad.2022.01.035. 2022


2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11611. 2021


A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.

Torres-Navarro I; (...); Botella-Estrada R

Letter. 10.1111/jdv.16664. 2020


A Case of Localised Immediate Hypersensitivity Reaction to Bimekizumab.

Lasheras-Perez, Miguel Antonio; (...); Ibanez-Echevarria, Ethel

Article. 10.1111/cod.14774. 2025


A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain

Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro

Article. 10.33393/grhta.2022.2333. 2022


A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.

Zozaya, Neboa; (...); Verde, Luis

Article. 10.1017/S0266462322000459. 2022


A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.

de Andrés-Nogales F; (...); Martínez-Olmos J

Article. 10.1007/s41669-020-00201-2. 2020


A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.

Casado, MA; (...); Grp MULTIDEX-EMD

Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018


A new definition and refocus of pharmaceutical care: the Barbate Document

Morillo-Verdugo R; (...); Poveda-Andrés JL

Article. 10.7399/fh.11389. 2020


A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study

Puig, Lluis; (...); IMPULSE Investigators Grp

Article. 10.1159/000540019. 2024


A prospective multicenter study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients

Ortiz-Salvador, JM; (...); Perez-Ferriols, A

Article. 10.1016/j.jaad.2019.02.062. 2019


A Pseudoxanthoma Elasticum-Like Papular Eruption: Challenge.

Sabater-Marco V, Sanz-Motilva V, Botella-Estrada R

Article. 10.1097/DAD.0000000000000489. 2017


A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.

Dirschka T; (...); Puig S

Article. 10.1111/jdv.15185. 2019


A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis

Canueto, J; (...); Sanmartin, O

Review. 10.1016/j.ad.2019.06.005. 2020


Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma

de Unamuno Bustos, B; (...); Botella Estrada, R

Article. 10.1111/bjd.16254. 2018


Absolute PASI and secukinumab in plaque psoriasis: Experience of clinical practice in a tertiary Hospital of Valencia, Spain

Piqueras-Garcia, J; (...); BotellaEstrada, R

Meeting Abstract. 2019


Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis

Torres-Navarro, I; (...); Botella-Estrada, R

Article. 10.1111/1346-8138.15490. 2020


Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis

Torres-Navarro, I, Briz-Redon, A, Botella-Estrada, R

Review. 10.1111/jdv.16137. 2020


Acute Necrotic Plaque in an Immunocompromised Host

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Editorial Material. 10.1097/DAD.0000000000000470. 2017


Acute Necrotic Plaque in an Immunocompromised Host

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Editorial Material. 10.1097/DAD.0000000000000471. 2017


Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.

Ballesta-López O; (...); Poveda-Andrés JL

Article. 10.1177/1078155220915953. 2020


Advanced type 1 hyperoxaluria presenting as livedo racemosa in a patient with end-stage renal disease

Torres-Navarro, I; (...); Moral-Moral, P

Letter. 10.4103/ijdvl.IJDVL_1030_18. 2019


Analysing criteria for price and reimbursement of orphan drugs in Spain.

Badia, X; (...); Tort, M

Article. 10.7399/fh.11147. 2019


Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/10781552211038518. 2021


Anti-Mi-2 Dermatomyositis with ulcerative plaques.

Palacios-Diaz RD; (...); Botella-Estrada, Rafael

Article. 10.1093/rheumatology/keac180. 2022


Antimicrobial stewardship programme implementation in a medical ward

Ruiz, J; (...); Poveda, JL

Article. 2018


Antimicrobial stewardship programme in critical care medicine: A prospective interventional study

Ruiz, J; (...); Catellanos, A

Article. 10.1016/j.medin.2017.07.002. 2018


Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023


Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic

Roca-Gines, J; (...); Evole-Buselli, M

Article. 10.1001/jamadermatol.2020.2340. 2020


Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study

Avallone, Gianluca; (...); Quaglino, Pietro

Article. 10.2340/actadv.v102.319. 2022


Asymptomatic Annular Plaques in a 67-Year-Old Man

de Unamuno Bustos B; (...); Estrada, RB

Article. 10.1097/DAD.0000000000000507. 2017


Asymptomatic Annular Plaques in a 67-Year-Old Man: Challenge.

de Unamuno Bustos B; (...); Estrada RB

Article. 10.1097/DAD.0000000000000506. 2017


Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021


Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018


Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2018.12.027. 2019


Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022


BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings.

Munera-Campos M; (...); Carrascosa JM

Article. 10.1016/j.ad.2023.03.001. 2023


BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population

Perez-Huertas, P; (...); Poveda-Andres, JL

Article. 10.1177/1043454216631952. 2017


Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience

Garcia-Robles, AA; (...); Fernandez-Navarro, JM

Meeting Abstract. 2017


Casal necklace.

Mansilla-Polo, Miguel, Martin-Torregrosa, Daniel, Botella-Estrada, Rafael

Article. 10.1016/j.medcli.2023.03.035. 2023


Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group

Sahuquillo-Torralba, Antonio; (...); Gallardo, Fernando

Article. 10.1111/ijd.17238. 2024


Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2021.07.009. 2021


Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

Sanmartin, O; (...); Gravalos, C

Article. 10.1016/j.ad.2019.01.011. 2019


Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

Gravalos, C; (...); Botella, R

Article. 10.1007/s12094-018-1953-x. 2019


Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019


Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV).

Botella-Estrada R; (...); García-Doval I

Article. 10.1016/j.ad.2020.07.003. 2021


Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease.

Bonanad, C; (...); Botella-Estrada, R

Article. 10.1016/j.ad.2016.12.023. 2017


Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-alpha inhibitors.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.1111/ddg.15007. 2023


Collaborative model of home delivery program in haemophilia through an association of patients

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018


Coma blisters. A key to neurological diagnosis.

Torres-Navarro I; (...); Botella-Estrada R

Letter. 10.1016/j.nrl.2018.11.005. 2020


Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19

Torres-Navarro, I; (...); Evole-Buselli, M

Letter. 10.1111/ced.14255. 2020


Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Megias-Vericat, JE; (...); Poveda, JL

Meeting Abstract. 2020


Complete response of a locally advanced basosquamous carcinoma with vismodegib treatment

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Letter. 10.4103/ijdvl.IJDVL_647_18. 2019


Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS

Ruiz-Salas, Veronica; (...); Garcia-Doval, Ignacio

Article. 10.1159/000517010. 2021


Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023


Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023


Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients A Delphi Consensus Statement

Massey, Paul R.; (...); Jambusaria-Pahlajani, Anokhi

Article. 10.1001/jamadermatol.2021.3180. 2021


Contact dermatitis by face mask.

Mansilla-Polo M, Navarro-Mira MÁ, Botella-Estrada R

Article. 10.1016/j.medcli.2023.01.004. 2023


Correction: 'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.

Mansilla-Polo M; (...); Botella-Estrada R

Correction. 10.1007/s15010-024-02259-0. 2024

  • Open Access.

Corrigendum to "Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients" [Clin. Biomech. volume 68 (2019) Pages 169-174/Article Number JCLB 4795].

Olmos CMF; (...); Ivorra JAR

Correction. 10.1016/j.clinbiomech.2019.10.023. 2020


COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

  • Open Access.

COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024


Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1080/13696998.2017.1311903. 2017


Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020


COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN

Trillo, JL; (...); Torres, C

Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018


COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020


Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021


Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis

Megias-Vericat, JE; (...); Poveda, JL

Letter. 10.1111/hae.13733. 2019


Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019


Current Status of Multidisciplinary Care in Psoriatic Arthritis in Spain: NEXUS 2.0 Project.

Queiro R; (...); Gratacos J

Article. 10.1016/j.reuma.2018.01.010. 2020


Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.

Garrido-Jareño M; (...); Pemán-García J

Article. 10.1186/s13071-020-3901-1. 2020


Cutaneous larva migrans.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1016/j.medcli.2023.03.037. 2023

  • Open Access.

Cutaneous sarcoidosis after platelet-rich plasma injections and permanent eyebrow make-up.

Torregrosa DM; (...); Estrada RB

Case Reports. 10.1016/j.ad.2023.06.023. 2024


Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024


Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm Registry.

Ruiz-Genao DP; (...); García-Doval I

Article. 10.1016/j.ad.2020.05.008. 2020


Chikungunya fever with a positive tourniquet test: a novel description.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1093/ced/llae089. 2024


Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1080/17512433.2019.1573668. 2019


Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project

Blade, J; (...); Lizan, L

Article. 10.1136/bmjopen-2017-018850. 2018


Delusional parasitosis (Ekbom's syndrome).

Mansilla-Polo, M, Martin-Torregrosa, D, Botella-Estrada, R

Article. 10.1016/j.semerg.2024.102423. 2024


Dermatologic Consultations for Patients Hospitalized in Non-Dermatologic Wards: Results of a 384-Patient Cross-Sectional Study From a Tertiary Referral Hospital

Mansilla-Polo, M.; (...); Botella-Estrada, R.

Letter. 10.1016/j.ad.2024.10.030. 2024

  • Open Access.

Dermatologic consultations for patients hospitalized in non-dermatologic wards: results of a 384-patient cross-sectional study from a tertiary referral hospital.

Mansilla-Polo, M; (...); Botella-Estrada, R

Case Reports. 10.1016/j.ad.2023.11.021. 2023


Dermatological toxicities of talquetamab, a new bispecific antibody: case series and literature review.

Mansilla-Polo M; (...); Botella-Estrada R

Letter. 10.1111/ddg.15502. 2024


Dermatological toxicities of talquetamab, a new bispecificantibody: case series and literature review

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Letter. 10.1111/ddg.15502_g. 2024


Dermatomyositis panniculitis: A case series and review of the literature

Calle, A; (...); Santos-Briz, A

Meeting Abstract. 2018


Design and implementation of a custom targeted next-generation sequencing panel in a series of primary melanomas

De Unamuno, B; (...); Botella, R

Meeting Abstract. 2017


Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021


Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019


DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019


Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024


Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024


DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019


Development and validation of a model to predict complex Mohs Micrographic Surgery in clinical practice: REGESMOSH scale.

Montero-Vilchez, Trinidad R.; (...); Sanmartin-Jimenez, Onofre

Article. 10.1111/jdv.19056. 2023


Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019


Diagnosis of Lung Cancer Due to a Complicated Abscess.

Torres-Navarro I, Piqueras-García J, Botella-Estrada R

Editorial Material. 10.1016/j.ad.2018.01.020. 2019


Differences in epidemiology, comorbidities and treatment choice between plaque psoriasis and pustular psoriasis: results from the Biobadaderm registry.

Ruiz Genao, Diana P.; (...); Garcia-Doval, Ignacio

Letter. 10.1111/bjd.21763. 2022


Diffusion tensor imaging as a prognostic biomarker for motor recovery and rehabilitation after stroke

Puig, J; (...); Pedraza, S

Review. 10.1007/s00234-017-1816-0. 2017


Divided or kissing nevus of the penis: A new case with dermoscopic findings

Armengot-Carbo, M, Rodrigo-Nicolas, B, Botella-Estrada, R

Article. 10.1111/pde.13556. 2018


DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis

Sanz-Garcia, A; (...); Ovejero-Benito, MC

Article. 10.2340/00015555-3794. 2021


Does hyaluronidase injected in periocular area change skin ultrastructure?: Standardized in vitro analysis

Aguilar-González M; (...); Pérez-López M

Article. 10.1111/jocd.15014. 2022


Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting

Daudén E; (...); Llamas-Velasco M

Article. 10.1111/ijd.16915. 2024


Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study

Lasheras-Pérez MA; (...); Rodríguez-Serna M

Article. 10.1111/ijd.17030. 2024


Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.

Phan, Duc Binh; (...); Yiu ZZN

Article. 10.1136/bmjopen-2023-075197. 2023


Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study

Duc Binh Phan; (...); Yiu, Zenas Zee Ngai

Meeting Abstract. 2024


Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study.

Phan, Duc Binh; (...); Yiu, Zenas Z N

Article. 10.1093/bjd/ljae454. 2024


Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).

Rodriguez, C Couselo; (...); Florez, A.

Article. 10.1016/j.ad.2023.07.014. 2023


Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study

Lopez-Ferrer, Anna; (...); Puig, Lluis

Article. 10.1111/dth.15831. 2022


Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases

Megias-Vericat, JE; (...); Poveda, JL

Review. 10.1007/s10072-017-2833-9. 2017


Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Ribera, E; (...); Hernandez-Novoa, B

Article. 10.1016/j.eimc.2016.11.015. 2018


Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020


Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort

Hernandez-Fernandez, CP; (...); Garcia-Doval, I

Article. 10.2340/00015555-3711. 2021


Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population.

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Article. 10.1111/ajd.14130. 2023


Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.

del Alcazar, Elena; (...); Carrascosa YJM

Article. 10.1111/dth.15231. 2022


Effectiveness in the treatment of solar urticaria with omalizumab: Report of 7 cases

Sahuquillo-Torralba, A, Rodriguez-Serna, M, Botella Estrada R

Letter. 10.1016/j.medcli.2018.01.003. 2018


Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021


Effectiveness of Secukinumab for the treatment of erythrodermic psoriasis. Multicenter study in daily practice.

Reymundo, A; (...); Dauden, E

Letter. 10.1111/jdv.19371. 2023


Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice.

Mansilla-Polo M; (...); Botella-Estrada R

Letter. 10.1111/ajd.14151. 2023


Efficacy of Risankizumab in Patients with Suboptimal Response or Failure to Ustekinumab: A Multicenter Retrospective Study in Spain

Magdaleno-Tapial, Jorge; (...); Martorell-Calatayud, Antonio

Article. 10.1155/2024/5528484. 2024


eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Megias-Vericat, JE

Meeting Abstract. 2018


Erfolgreiche Imatinib-Therapie einer mit dem myeloproliferativen hypereosinophilen Syndrom mit PDGFRA-Rearrangement assoziierten lymphomatoiden Papulose

Torres-Navarro I; (...); Botella-Estrada R

Letter. 10.1111/ddg.14064_g. 2020


Erosions and blisters in a premature infant with exclusive breastfeeding.

Sahuquillo-Torralba A; (...); Évole-Buselli M

Article. 10.1016/j.medcli.2016.12.040. 2017


Erythema Elevatum Diutinum.

Mansilla-Polo M, Botella-Estrada R

Article. 10.1016/j.ad.2023.10.042. 2024

  • Open Access.

Erythemato-violaceous plaques on the shin of a trasplanted lung host.

Sahuquillo-Torralba A; (...); Botella-Estrada R

Article. 10.1016/j.medcli.2017.05.024. 2017


Erythrodermic psoriasis and secukinumab: Our clinical experience

Mateu-Puchades, A; (...); Sanchez-Carazo, JL

Letter. 10.1111/dth.12607. 2018


EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019


Experience of Home Delivery Program in Haemophilia Through an Association of Patients

Megias Vericat, J. E.; (...); Bonanad Boix, S.

Meeting Abstract. 2017


Exploratory analysis for the implementation of antineoplastic logarithmic dose banding

Albert-Mari, A; (...); Poveda-Andres, JL

Article. 10.1007/s11096-018-0714-9. 2018


EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019


Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting

Chicharro, Pablo; (...); Dauden, Esteban

Article. 10.1111/dth.15653. 2022


Fatal outcome in classic Kaposi's sarcoma.

Mansilla-Polo M, Botella-Estrada R

Article. 10.1016/j.ad.2023.03.013. 2024


Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease

Beltran, B; (...); Nos, P

Article. 10.1159/000492626. 2019


Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021


Folliculitis Decalvans Caused by Bacterial Superinfection Secondary to Erlotinib.

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Letter. 10.1016/j.ad.2017.02.032. 2018


Folliculotropic Mycosis Fungoides With Flexural Eruptive Cysts and Comedones in a 14-Year-Old Boy.

Roca-Gines, J; (...); Botella-Estrada, R

Article. 10.1097/DAD.0000000000001958. 2021


Generalized non-evanescents wheals with targetoid purpuric plaques.

Sahuquillo-Torralba A; (...); Botella-Estrada R

Article. 10.1016/j.medcli.2017.10.006. 2018


Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice.

Butrón-Bris B; (...); de la Fuente H

Article. 10.1111/exd.15152. 2024


Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024


Granulomatous plaque of the right knee in a 10-year-old boy.

Sahuquillo-Torralba A; (...); Évole-Buselli M

Editorial Material. 10.1016/j.eimc.2017.03.006. 2019


Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022


Guselkumab, Risankizumab, and Tildrakizumab demonstrate parallel effectiveness and safety in psoriasis treatment: a head-to-head comparative study in real clinical practice.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1016/j.abd.2024.04.004. 2024


Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12568. 2017


Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study

Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units

Article. 10.7399/fh.10935. 2018


Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022


Hemihypoatrophy as an extraordinary manifestation of linear morphoea.

Mansilla-Polo, Miguel, Navarro-Mira, Miguel A., Botella-Estrada, Rafael

Article. 10.1093/rap/rkac104. 2022


Heparin hemorrhagic bullae induced by enoxaparin.

Torres-Navarro I, de Unamuno-Bustos B, Pujol-Marco C

Letter. 10.1016/j.medcli.2019.09.012. 2019


Herpes vegetans of the vulva.

Abril-Pérez C; (...); Botella-Estrada R

Article. 10.1016/j.ajog.2021.05.024. 2021


High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting

Martos-Cabrera, Luisa; (...); Dauden, Esteban

Letter. 10.1111/ijd.16365. 2022


High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022


High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke

Puig, J; (...); Castellanos, M

Article. 10.1371/journal.pone.0188238. 2017


Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence.

Verdaguer-Faja, Julia; (...); Jaka, Ane

Article. 10.1111/jdv.20250. 2024


Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022


Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021


How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022


How does SCORTEN score?

Navarro, IT; (...); Botella-Estrada, R

Meeting Abstract. 2019


Identification of c.104T>G, p.Met35Arg (NM_00314.8) variant in heterozygosity in exon 2 of the PTEN gene as the Causative Factor for Cowden Syndrome: A Medical Case Study.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1093/ced/llad344. 2023


IMAPSORS project: A multicenter validation study to assess the accuracy of an artificial intelligence solution to quantify psoriasis severity

Martorell, A; (...); Llamas, M

Meeting Abstract. 2021


Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2016.1231405. 2017


Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis

Edo Solsona MD; (...); Poveda Andrés JL

Article. 10.2147/PPA.S127508. 2017


IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS

Edo-Solsona, M.; (...); Poveda-Andres, J.

Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016

  • Open Access.

Impact of an antimicrobial stewardship program on critical haematological patients.

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.7399/fh.2017.41.4.10709. 2017


Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020


Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1038/tpj.2017.19. 2018


Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1097/FPC.0000000000000286. 2017


Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020


Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019


Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020


Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1159/000478969. 2018


Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis.

Baniandrés-Rodríguez O; (...); García-Doval I

Letter. 10.1016/j.jaad.2020.10.046. 2021


Incomplete Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery).

Oro-Ayude, M.; (...); REGESMOHS (Registro Español de Cirugía de Mohs)

Letter. 10.1111/jdv.17597. 2022


Indeterminate Cell Histiocytosis in Children: A Case Report.

Sahuquillo-Torralba, A.; (...); Botella-Estrada, R.

Letter. 10.1016/j.ad.2017.01.022. 2017


Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Vericat, JEM; (...); Bonanad, S

Meeting Abstract. 2018


Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago

Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016


Infectious pubic plaque.

Torres-Navarro, Ignacio; (...); Botella-Estrada, Rafael

Editorial Material. 10.1016/j.eimc.2019.03.004. 2019


Inflammatory tinea manuum: The importance of pustules.

Sahuquillo Torralba A, Navarro Mira MÁ, Botella Estrada R

Article. 10.1016/j.medcli.2016.10.020. 2017


Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019


Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2017.1323267. 2017


Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.

Ruiz J; (...); Poveda JL

Article. 10.23736/S0026-4946.18.04978-2. 2018


Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021


Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma

Gutzmer, Ralf; (...); Hauschild, Axel

Article. 10.1186/s12885-024-13101-z. 2024


Interparietal nodule in a 49-year-old woman.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Case Reports. 10.1111/ddg.15398. 2024


Interparietaler Knoten bei einer 49-jährigen Frau

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1111/ddg.15398_g. 2024


Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019


Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020


Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020


Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024


Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024


Kidney Disease and Psoriasis. A New Comorbidity?

González-Parra E; (...); Rivera R

Article. 10.1016/j.ad.2016.05.009. 2016


Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-a-Inhibitoren behandelten Patienten.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.1111/ddg.15007_g. 2023


Leishmaniasis in patients undergoing biologic and immunosuppressive treatment: Case-control multicenter study

Sahuquillo-Torralba, A; (...); Rocamora, V

Meeting Abstract. 2020


'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1007/s15010-024-02214-z. 2024


Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry

Dauden, E; (...); Garcia-Doval, I

Article. 10.1016/j.jaad.2020.03.033. 2020


Lymph Node Dissection in Patients with Melanoma and Sentinel Lymph Node Metastasis: An Updated, Evidence-Based Decision Algorithm

Moreno-Ramirez, D; (...); Academia Espanola Dermatologia Ven

Article. 10.1016/j.ad.2018.02.008. 2018


Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study.

Rivera R; (...); Carrascosa JM

Letter. 10.1111/jdv.16809. 2020


Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

  • Open Access.

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022


Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021


Melanoma and LEOPARD Syndrome: Understanding the Role of PTPN11 Mutations in Melanomagenesis.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.2340/actadv.v104.14720. 2024


Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022


Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020


MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.

Murria Estal, Rosa; (...); Botella Estrada, Rafael

Article. 10.1097/CMR.0000000000000709. 2020


MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase.

Tarazon, Estefania; (...); Botella Estrada, Rafael

Article. 10.3390/genes12121931. 2021


Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience.

Nieto Benito LM; (...); García-Doval I

Case Reports. 10.1016/j.ad.2021.05.017. 2022


Mohs micrographic surgery in dermatofibrosarcoma protuberans: Rate and risk factors for recurrence in a prospective cohort study from the Spanish Registry of Mohs Surgery (REGESMOHS) and review of the literature.

Nieto-Benito LM; (...); Garcia-Doval I

Review. 10.1111/exd.14291. 2021


Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery).

Abril-Pérez C; (...); Botella-Estrada R

Article. 10.1111/jdv.20103. 2024


Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021


Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021


Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.

Fernandez-Megia, MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.10793. 2018


MORPHOLOGICAL CHARACTERIZATION OF THE CUTANEOUS BIOPSIES IN THE EICH: INFLAMMATORY INFILTRATION STUDY AND THE EXPRESSION OF ELAFIN

Moles Poveda, P.; (...); Sanz Caballer, J.

Meeting Abstract. 2018

  • Open Access.

Multidisciplinary Care Models for Patients With Psoriatic Arthritis.

Queiro, R; (...); Gratacos, J

Article. 10.1016/j.reuma.2016.03.005. 2017


Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021


MULTIPLE INFECTION IS INDEPENDENTLY RELATED TO DEATH IN ADULT PATIENTS WITH HEMOPHAGOCYTIC SYNDROME: ETIOPATHOGENICALLY-DRIVEN MULTIVARIATE ANALYSIS IN 151 PATIENTS

Retamozo, S; (...); Reghem-geas-semi Study Grp

Meeting Abstract. 10.1136/annrheumdis-2018-eular.4112. 2018

  • Open Access.

Multiple pilomatricomas in a child with xeroderma pigmentosum: Coincidence or association?

Palacios-Diaz RD; (...); Botella-Estrada R

Article. 10.1111/pde.14924. 2022


Multiple Primary Melanomas: Retrospective Review in a Tertiary Care Hospital

Palacios-Diaz RD; (...); Botella-Estrada R

Article. 10.3390/jcm11092355. 2022


Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.

Mansilla-Polo M, Escutia-Muñoz B, Botella-Estrada R

Article. 10.1016/j.ad.2023.08.001. 2023


Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.

Mansilla-Polo, M., Escutia-Munoz, B., Botella-Estrada, R.

Article. 10.1016/j.ad.2023.05.015. 2023


National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021


National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022


New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024


Nodular hidradenoma: Case report and brief literature review.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1016/j.patol.2025.100801. 2025


Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022


ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023


Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023


One Dose Risankizumab Effectiveness in Psoriasis: A Real-Life Multicentre Study

Magdaleno-Tapial, Jorge; (...); Sanchez-Carazo, Jose Luis

Article. 10.1155/2024/4866592. 2024


Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Poveda, JL

Meeting Abstract. 2018


OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024


Oral Ruxolitinib could Increase the Aggressiveness of Cutaneous Squamous Cell Carcinomas: A 6-Patient Series

Lasheras-Perez, M. A.; (...); Botella-Estrada, R.

Letter. 10.1016/j.ad.2023.07.035. 2025


Pancreatic panniculitis.

Torres-Navarro I, Rojas-Ferrer N, Botella-Estrada R

Article. 10.17235/reed.2019.6116/2018. 2019


Papulonecrotic tuberculides as a key to the diagnosis of tuberculosis: a case report.

Mansilla-Polo M; (...); Botella-Estrada R

Letter. 10.1111/ijd.16940. 2024


Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020


Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022


Paradoxical psoriasiform reactions by anti-TNF treated with Ustekinumab in patients with inflammatory bowel disease

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Meeting Abstract. 2019


Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021


Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

  • Open Access.

Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.

Sánchez-Velázquez A; (...); Ortiz-Romero PL

Letter. 10.1111/jdv.17430. 2021


Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020


Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.

Munoz-Aceituno, E.; (...); de la Fuente, H.

Article. 10.1111/jdv.19782. 2023


Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

  • Open Access.

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.2174/1389200218666171101124931. 2018


Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021


Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022


Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

Calleja Hernández MÁ; (...); Aragon, B

Article. 10.7399/fh.2017.41.1.10463. 2017


Photosafety of the antidiabetic drug sitagliptin

Dubon, A; (...); ANDREU, I.

Letter. 10.1111/phpp.12475. 2019


Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)

Querol-Fuentes, F; (...); Bonanad, S

Meeting Abstract. 2017


Pilot evaluation of home delivery programme in haemophilia

Megias-Vericat, JE; (...); Poveda-Andres, JL

Article. 10.1111/jcpt.12718. 2018


PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020


Pleomorphic cutaneous Rosai-Dorfman disease

Martinez-Ciarpaglini, C; (...); Monteagudo, C

Letter. 10.1111/his.13101. 2017


Podoconiosis.

Mansilla-Polo, Miguel, Lopez-Leon, Paula Teresa, Botella-Estrada, Rafael

Article. 10.1001/jamadermatol.2023.4143. 2023


Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature

Gratacos-Masmitja, J; (...); Lopez-Estebaranz, JL

Review. 10.1007/s12325-016-0429-z. 2017


Position statement for the management of comorbidities in psoriasis

Dauden, E; (...); Rivera, R

Article. 10.1111/jdv.15177. 2018


Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process

Valero, S; (...); Poveda, JL

Article. 10.1016/j.yrtph.2018.03.001. 2018


PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019


Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021


Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021


Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

  • Open Access.

Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study

Sampogna, F.; (...); EPIDEPSO Investigators

Article. 10.1111/bjd.15243. 2017


Primary cutaneous embryonal rhabdomyosarcoma with desmoplastic growth pattern and anaplastic lymphoma kinase overexpression. Report of a case with special emphasis on the differential diagnosis.

Sabater-Marco V; (...); Botella-Estrada R

Letter. 10.1111/ced.13877. 2019


Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.

Falkenhain-Lopez, D; (...); Ortiz-Romero, P L

Article. 10.1016/j.ad.2022.11.010. 2023


Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry.

Torre-Castro J; (...); Machan S

Article. 10.1111/pde.14811. 2021


Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021


Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study.

Marti-Marti I; (...); Toll A

Article. 10.1016/j.jaad.2023.02.048. 2023


Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler

Megias-Vericat, JE; (...); Poveda, JL

Letter. 10.1097/DSS.0000000000001046. 2017


Pseudoxanthoma Elasticum-Like Papular Eruption

Sabater-Marco, Vicente, Sanz-Motilva, Virginia, Botella-Estrada, Rafael

Article. 10.1097/DAD.0000000000000490. 2017


Psoriasis and Nonalcoholic Fatty Liver Disease.

Carrascosa, JM; (...); Olveira-Martin, A

Article. 10.1016/j.ad.2016.12.017. 2017


Psoriasis onset over a fresh tattoo.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Article. 10.1016/j.medcli.2022.01.014. 2022


Pyoderma Gangrenosum With Ulcerative Colitis Successfully Treated With Ustekinumab.

Piqueras-García J; (...); Botella-Estrada R

Letter. 10.1016/j.ad.2018.03.034. 2019


Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker

Perez-Alenda, S; (...); Querol, F

Letter. 10.1111/hae.13388. 2018


Raccoon eyes as a diagnostic key for suspected amyloidosis

Mansilla-Polo, Miguel, Botella-Estrada, Rafael

Editorial Material. 10.1093/rap/rkad105. 2023


Rapidly growing retroarticular tumor: the importance of physical examination

Torres-Navarro, I, Piqueras-Garcia, J, Botella-Estrade, R

Editorial Material. 2018


Rapidly progressive frontal necrotic plaque in an immunosuppressed host

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Editorial Material. 10.1016/j.eimc.2017.01.003. 2018


Rapidly progressive violaceous and necrotic plates in a 5-year-old child

Sahuquillo-Torralba A; (...); Evole-Buselli, M

Editorial Material. 10.1016/j.medcli.2017.03.033. 2018


Rationale and study design for an Individualized PeriopeRative Open lung VEntilatory approach in Emergency Abdominal Laparotomy/scopy: study protocol for a prospective international randomized controlled trial.

Laguna G; (...); Ferrando C

Article. 10.1016/j.redare.2024.04.007. 2024


Reactive arthritis.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1016/j.medcli.2023.08.017. 2023


Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group.

Del Alcázar E; (...); Carrascosa JM

Article. 10.1111/jdv.16439. 2020


Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1111/ajd.14339. 2024


Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study.

Martorell A; (...); Magdaleno-Tapial J

Article. 10.1016/j.ad.2024.10.042. 2024


Recalcitrant Hailey-Hailey Disease With Satisfactory Response to Apremilast

Mansilla-Polo, M.; (...); Botella-Estrada, R.

Letter. 10.1016/j.ad.2024.10.025. 2024


Recalcitrant Hailey-Hailey Disease With Satisfactory Response to Apremilast.

Mansilla-Polo, M; (...); Botella-Estrada, R

Case Reports. 10.1016/j.ad.2023.05.022. 2023


Recalcitrant lichen planopilaris treated with upadacitinib: a case series

Lasheras-Perez, Miguel A.; (...); Botella-Estrada, Rafael

Article. 10.1111/ijd.17339. 2024


Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology.

Cuéllar Monreal MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.2017.41.1.10434. 2017


Refractory acute graft versus host disease treated with extracorporeal photopheresis

Moles-Poveda, P; (...); Estrada, RB

Meeting Abstract. 2017


Refractory cutaneous lupus erythematosus successfully treated with anifrolumab: a case series.

Martin-Torregrosa, Daniel; (...); Torres-Navarro, Ignacio

Letter. 10.1111/ijd.17022. 2024


Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients.

Feced Olmos CM; (...); Román Ivorra JA

Article. 10.1016/j.clinbiomech.2019.06.009. 2019


Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.

Sanchez-Diaz, M.; (...); Carrascosa-Carrillo, J. M.

Article. 10.1016/j.ad.2023.10.016. 2023


Retrospective research of cutaneous and mucosal leishmaniasis in a Spanish hospital of an endemic zone of Leishmania donovani infantum infection

Sahuquillo, Antonio; (...); Botella, Rafael

Meeting Abstract. 2017


Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)

Tomas-Velazquez, Alejandra; (...); Redondo, Pedro

Article. 10.2340/actadv.v101.544. 2021


Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.

Miñano Medrano R; (...); García-Doval I

Article. 10.1016/j.ad.2022.01.003. 2022


Risk of Hepatitis B Virus Reactivation in Patients on Secukinumab for Psoriasis: A Series of 4 Cases

Moneva-Leniz, LM; (...); Mateu-Puchades, A

Letter. 10.1016/j.ad.2019.02.022. 2020


Role of microRNAs in the pathogenesis of melanoma

Murria, Rosa; (...); Botella, Rafael

Meeting Abstract. 2017


Role of the Dermatologist in the Care of Hospitalized Transplant Patients

Escutia Muñoz B

Editorial Material. 10.1016/j.ad.2018.11.001. 2018


Ruxolitinib for foreign body reaction to silicone in a patient with chronic graft-versus-host disease.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Letter. 10.1111/ijd.17365. 2024


Ruxolitinib oral puede aumentar la agresividad de los carcinomas escamosos cutáneos: serie de 6 pacientes.

Lasheras-Perez MA; (...); Botella-Estrada R

Article. 10.1016/j.ad.2024.10.003. 2025


Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.

Lluch-Galcera, Juan Jose; (...); Garcia-Doval, Ignacio

Article. 10.1093/bjd/ljad382. 2023


Safety of biosimilars compared with originator adalimumab for psoriasis: a multinational cohort study

Phan, Duc Binh; (...); Yiu, Zenas

Meeting Abstract. 10.1093/bjd/ljae360.068. 2024

  • Open Access.

Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.

Sole, A; (...); Peman, J

Article. 10.1111/ajt.14580. 2018


Sarcoidosis cutánea tras inyecciones de plasma rico en plaquetas y maquillaje permanente de cejas.

Martín-Torregrosa D; (...); Botella-Estrada R

Article. 10.1016/j.ad.2024.10.043. 2024

  • Open Access.

Scaling and periorificial crusts in a pediatric patient.

Fayos-Gregori, Rafael; (...); Botella-Estrada, Rafael

Article. 10.1007/s15010-024-02309-7. 2024


Scalp Melanoma: A High-Risk Subset of Cutaneous Head and Neck Melanomas with Distinctive Clinicopathological Features.

Palacios-Diaz RD; (...); Botella-Estrada R

Article. 10.3390/jcm12247643. 2023


Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective.

Moles-Poveda, P; (...); Botella-Estrada, R

Article. 10.1016/j.ad.2017.11.003. 2018


Secukinumab is effective and safe in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.

Reolid, Alejandra; (...); Dauden, Esteban

Article. 10.1016/j.jaad.2022.05.047. 2022


SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020


Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study.

Tejera-Vaquerizo, Antonio; (...); Nagore, Eduardo

Article. 10.3390/jcm10245878. 2021


Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice

Aguas Peris M; (...); Nos, P

Article. 10.1097/MIB.0000000000001182. 2017


Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice

Aguas, M; (...); Nos, P

Meeting Abstract. 2017


SfM-3DULC: Reliability of a new 3D wound measurement procedure and its accuracy in projected area.

Sánchez-Jiménez D; (...); Botella-Estrada R

Article. 10.1111/iwj.13595. 2021


Single Digital Metastasis of Rectal Adenocarcinoma

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Letter. 10.1097/DAD.0000000000002529. 2023

  • Open Access.

Skin Cancer and the Dermatologist: Reflections on the Position Taken by the Spanish Society of Medical Oncology (SEOM).

Moreno-Ramirez, D; (...); Malvehy, J

Article. 10.1016/j.ad.2017.06.003. 2017


Skin cancer risk after hematopoietic stem cell transplantation: a systematic review and meta-analysis.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1111/ijd.17371. 2024


Skin lesions in a lung transplant recipient

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Editorial Material. 10.1016/j.eimc.2023.09.005. 2024

  • Open Access.

Skin lesions in a lung transplant recipient.

Mansilla-Polo M; (...); Botella-Estrada R

Case Reports. 10.1016/j.eimce.2023.09.005. 2024

  • Open Access.

SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022


Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma.

Sanmartín O; (...); Puig S

Review. 10.1016/j.ad.2020.11.002. 2021


Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain

Gratacos, J; (...); Queiro, R

Article. 10.1007/s00296-018-3986-4. 2018


State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS).

Rodríguez-Jiménez P; (...); Descalzo MA

Article. 10.1111/ijd.14732. 2020


Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma

Diaz, Rodolfo David Palacios; (...); Estrada, Rafael Botella

Article. 10.1111/cup.14758. 2025


STUDY OF THE EFFECTIVENESS OF IMATINIB IN CHRONIC GRAFT-VERSUS-HOST DISEASE IN A SERIES OF 19 CASES

Poveda, PM; (...); Caballer, JS

Meeting Abstract. 2017

  • Open Access.

Successful treatment of erythema nodosum leprosum with apremilast.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Letter. 10.1111/dth.15258. 2022


Successful treatment of erythema nodosum leprosum with upadacitinib and roflumilast.

Mansilla-Polo, Miguel; (...); Torres-Navarro, Ignacio

Letter. 10.1111/ijd.17293. 2024


Successful treatment of field of cancerization in the dorsum of the hands with 1% tirbanibulin ointment.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Article. 10.1093/ced/llad171. 2023


Successful Treatment of Mogamulizumab-Associated Rash With Upadacitinib: Evidence From 2 Cases.

Martin-Torregrosa, Daniel; (...); Botella-Estrada, Rafael

Article. 10.1001/jamadermatol.2024.4582. 2024


Successful Treatment of Stimulator of Interferon Genes-Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1001/jamadermatol.2024.2160. 2024


Successful treatment with imatinib of lymphomatoid papulosis associated with myeloproliferative hypereosinophilic syndrome with PDGFRA rearrangement.

Torres-Navarro I; (...); Botella-Estrada R

Case Reports. 10.1111/ddg.14064. 2020


Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.

Tejera-Vaquerizo, A; (...); SENTIMEL group

Article. 10.1002/cam4.2358. 2019


Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects.

Lasheras-Pérez MA; (...); Rodriguez-Serna M

Article. 10.1111/ijd.16926. 2024


Symmetrical pustulosis unfolds over systemic lupus.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Article. 10.1093/rheumatology/keab529. 2021


Systematic review of BRAF/MEK inhibitors-induced Severe Cutaneous Adverse Reactions (SCARs).

Torres-Navarro I, de Unamuno-Bustos B, Botella-Estrada R

Review. 10.1111/jdv.16894. 2020


Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Megías-Vericat JE; (...); Montesinos P

Review. 10.3390/pharmaceutics14040878. 2022


Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis.

Torres-Navarro I, Briz-Redón Á, Botella-Estrada R

Review. 10.1111/jdv.16685. 2020


Systemic therapies for toxic epidermal necrolysis and Stevens-Johnson syndrome: A SCORTEN-based systematic review and meta-analysis

Torres Navarro, Ignacio; (...); Botella-Estrada, Rafael

Meeting Abstract. 2020


Tattoo-Associated Common Wart

Mansilla-Polo, M., Llavador-Ros, M., Botella-Estrada, R.

Editorial Material. 10.1016/j.ad.2024.05.001. 2024

  • Open Access.

Tattoo-Associated Common Wart.

Mansilla-Polo, M, Llavador-Ros, M, Botella-Estrada, R

Article. 10.1016/j.ad.2023.04.037. 2023


Telomerase Expression in a Series of Melanocytic Neoplasms

Bustos, BD; (...); Estrada, RB

Article. 10.1016/j.ad.2018.10.003. 2019


The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil

Armengot-Carbo, M; (...); Botella-Estrada, R

Article. 10.1016/j.jaad.2017.12.064. 2018


The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity

Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar

Article. 10.1007/s00431-022-04628-z. 2022


The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Gil-Nagel A; (...); Gil A

Article. 10.1016/j.yebeh.2022.108711. 2022


The Female Sexual Function Index to assess patients with moderate to severe vulvar lichen sclerosus.

Gutierrez-Ontalvilla P; (...); Vicente D

Letter. 10.1684/ejd.2019.3580. 2019


The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry.

Munera-Campos, M; (...); Garcia-Doval, I

Article. 10.1080/09546634.2021.1922572. 2021


The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm registry: a prospective cohort study.

Sahuquillo-Torralba A; (...); García-Doval I

Letter. 10.1016/j.jaad.2019.07.028. 2020


The use of the vessel loop to bolster mattress sutures and prevent scars

MOLES, P.; (...); Botella-Estrada R

Editorial Material. 10.1016/j.jaad.2017.10.031. 2018


The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024


The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus

Torrent-Farnell, J; (...); Lizan, L

Article. 10.1016/j.healthpol.2018.03.002. 2018


Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020


Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy

Del Rio-Bermudez, C; (...); Poveda, JL

Editorial Material. 10.1186/s40545-020-00276-6. 2020


Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel

de Unamuno Bustos B; (...); Botella Estrada R

Article. 10.1038/s41598-017-00606-w. 2017


Toxic epidermal necrolysis with severe hepatic involvement

Torres-Navarro, I; (...); Botella-Estrada, R

Letter. 10.1111/ddg.14110. 2020


Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024


Toxische epidermale Nekrolyse mit schwerer hepatischer Beteiligung.

Torres-Navarro I; (...); Botella-Estrada R

Letter. 10.1111/ddg.14110_g. 2020


Treatment of palmoplantar psoriasis with oral roflumilast: a case series.

Lasheras-Perez, Miguel Antonio; (...); Botella-Estrada, Rafael

Article. 10.1093/ced/llae229. 2024


Treatment Persistence and Safety of Apremilast in Psoriasis: Experience With 30 Patients in Routine Clinical Practice

Sahuquillo-Torralba, A; (...); Estrada, RB

Article. 10.1016/j.ad.2018.10.031. 2020


Tumour-infiltrating lymphocyte and histological regression in primary melanoma.

Ribero S, Torres-Navarro I, Botella-Estrada R

Letter. 10.1007/s00403-020-02089-8. 2021


Two years results of electronic brachytherapy for basal cell carcinoma

Ballester-Sánchez R; (...); Botella-Estrada, R

Article. 10.5114/jcb.2017.68191. 2017


Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?

Bejar, S; (...); Mateu, PN

Meeting Abstract. 2020


Urticaria multiforme, an "erythema multiforme" simulator.

Torres-Navarro I, Sahuquillo-Torralba A, Botella-Estrada R

Article. 10.1016/j.medcli.2017.11.046. 2018


Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy

Garcia, SV; (...); Andres, JLP

Article. 10.1016/j.yrtph.2018.10.002. 2018


Use of an electrospun bioveil is safe and does not decrease skin graft take on burn wounds: A randomised, controlled clinical trial.

Perez-Del-Caz, Maria Dolores; (...); Perez-Plaza, Aranzazu

Article. 10.1016/j.burns.2025.107427. 2025


USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Dominguez Hernandez, L.; (...); Gomez Segui, I

Meeting Abstract. 2019

  • Open Access.

VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023


Vulvar and areolar fixed drug eruption.

Abril-Pérez C; (...); Botella-Estrada R

Article. 10.1016/j.ajog.2021.09.042. 2021


Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population.

Gonzalez-Cantero, A.; (...); Garcia-Doval, I.

Letter. 10.1111/bjd.18164. 2019


Zoon's vulvitis in association with severe vulvodynia.

Abril-Perez, Carlos; (...); Botella-Estrada R

Article. 10.1016/j.ajog.2022.01.033. 2022


Campos de estudio

Compartir